Drug Approval Package: Qbrexza (glycopyrronium)
Company: Dermira, Inc.
Application Number: 210361
Approval Date: 06/28/2018
Application Number: 210361
Approval Date: 06/28/2018
Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.
FDA Approval Letter and Labeling
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
FDA Application Review Files
Date created: November 20, 2018
Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.
Note: Documents in PDF format require the Adobe Acrobat Reader®.